Tomorrow Investor

PTX Metals Inc. Completes Surface Work at the Shining Tree Gold Property and Reports Multiple High-Grade Results from Surface Samples

PTX Metals: High-Grade Gold Results from Shining Tree Property | Newsfile Corp

Toronto, Ontario–(Newsfile Corp. – December 18, 2025) – PTX Metals Inc. (TSXV: PTX) (OTCQB: PANXF) (FSE: 9PX) (‘PTX’ or the ‘Company’) is pleased to announce completion of a structurally-oriented, geological review and the new, high-resolution, airborne magnetics survey of the northern and central portion of its Shining Tree Gold Property, located in South Timmins along the Ridout-Tyrrell Deformation Zone (also known as ‘RTDZ’) in Ontario, Canada. Sampling from the surface work resulted in multiple high-grade assays reported below.

This excerpt is quoted from the original release. Read the full announcement on Newsfile Corp.

Brief Summary

PTX Metals Inc. has successfully completed a significant geological review and a new airborne magnetic survey over key areas of its Shining Tree Gold Property. Located along the Ridout-Tyrrell Deformation Zone in Ontario, this initiative is expected to enhance exploration efforts significantly. Key findings include:

  • High-Grade Sample Assays: Multiple assays show promising results.
  • Advanced Survey Techniques: Utilization of high-resolution magnetic surveys.
  • Strategic Location: Situated in a mineral-rich mining area.

Why it matters: These developments position PTX for potential growth and increased investor interest as they advance their exploration efforts.

Read the Full Article

This is a summary of the press release. For the complete article and any additional details, please visit the original source.

Read Full Article

Attribution: Original press release by Newsfile Corp on . We provide an AI-generated summary and links for convenience. Always verify details with the original source. Not investment advice. For informational purposes only.

Tomorrow Investor
The Tomorrow Investor

Markets research for retail investors

Independent coverage of small-cap equities, biotech catalysts, and emerging market opportunities.